These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 10439163)

  • 1. Positron emission tomography in cancer patient management.
    Wahl RL
    Cancer J Sci Am; 1999; 5(4):205-7. PubMed ID: 10439163
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomographic imaging of the head and neck.
    Lee TH; Anzai Y; Huda A; Rege S; Hawkins R; Lufkin RB
    West J Med; 1993 Jul; 159(1):72. PubMed ID: 8351912
    [No Abstract]   [Full Text] [Related]  

  • 3. [Standards, Options and Recommendations for the use of PET-FDG in cancerology. Results in cancer of the upper aerodigestive tract].
    Bourguet P;
    Bull Cancer; 2003 Feb; 90 Spec No():S67-79. PubMed ID: 12739338
    [No Abstract]   [Full Text] [Related]  

  • 4. FDG positron emission tomography in head and neck cancer.
    Tecnologica MAP Suppl; 2000 Apr; ():6-9. PubMed ID: 11010673
    [No Abstract]   [Full Text] [Related]  

  • 5. Whole-body positron emission tomography: normal variations, pitfalls, and technical considerations.
    Gordon BA; Flanagan FL; Dehdashti F
    AJR Am J Roentgenol; 1997 Dec; 169(6):1675-80. PubMed ID: 9393189
    [No Abstract]   [Full Text] [Related]  

  • 6. Development of oncology protocol using fluorine-18-FDG: one center's experience.
    Cronin V; Galantowicz P; Nabi HA
    J Nucl Med Technol; 1997 Mar; 25(1):66-9. PubMed ID: 9239608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of positron emission tomography in occult primary head and neck cancers.
    Safa AA; Tran LM; Rege S; Brown CV; Mandelkern MA; Wang MB; Sadeghi A; Juillard G
    Cancer J Sci Am; 1999; 5(4):214-8. PubMed ID: 10439166
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Esophageal cancer and head and neck cancer.
    Lowe VJ; Stack BC
    Semin Roentgenol; 2002 Apr; 37(2):140-50. PubMed ID: 12134367
    [No Abstract]   [Full Text] [Related]  

  • 9. [Muscle uptake of 18FDG in positron emission tomography].
    Ortega F; Carreras JL; Maldonado A; Pérez-Castejón MJ; Montz R; Gorospe E; Ruiz JA; Nieto C
    Rev Esp Med Nucl; 1998; 17(2):120-1. PubMed ID: 9611283
    [No Abstract]   [Full Text] [Related]  

  • 10. A comparative diagnostic study of head and neck nodal metastases using positron emission tomography.
    McGuirt WF; Williams DW; Keyes JW; Greven KM; Watson NE; Geisinger KR; Cappellari JO
    Laryngoscope; 1995 Apr; 105(4 Pt 1):373-5. PubMed ID: 7715380
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduced F-18 FDG uptake with marrow may predict photopenia of corresponding vertebrae on bone scintigraphy.
    Shih WJ
    Clin Nucl Med; 2001 May; 26(5):480-1. PubMed ID: 11317046
    [No Abstract]   [Full Text] [Related]  

  • 12. PET image acquisition and analysis.
    Votaw JR
    Adv Neurol; 2000; 83():69-86. PubMed ID: 10999190
    [No Abstract]   [Full Text] [Related]  

  • 13. Prediction of survival with fluorine-18-fluoro-deoxyglucose and PET in head and neck cancer.
    Minn H; Lapela M; Klemi PJ; Grénman R; Leskinen S; Lindholm P; Bergman J; Eronen E; Haaparanta M; Joensuu H
    J Nucl Med; 1997 Dec; 38(12):1907-11. PubMed ID: 9430467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intense fluorodeoxyglucose activity in pulmonary amyloid lesions on positron emission tomography.
    Kung J; Zhuang H; Yu JQ; Duarte PS; Alavi A
    Clin Nucl Med; 2003 Dec; 28(12):975-6. PubMed ID: 14663319
    [No Abstract]   [Full Text] [Related]  

  • 15. Positron emission tomography scanning: a primer.
    Walker RC; Weiss DW; Purnell GL; Forte KF
    J Ark Med Soc; 2002 Oct; 99(4):119-21. PubMed ID: 12362654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FDG PET in head and neck cancer.
    Keyes JW; Watson NE; Williams DW; Greven KM; McGuirt WF
    AJR Am J Roentgenol; 1997 Dec; 169(6):1663-9. PubMed ID: 9393187
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer.
    Stokkel MP; Moons KG; ten Broek FW; van Rijk PP; Hordijk GJ
    Cancer; 1999 Dec; 86(11):2370-7. PubMed ID: 10590380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Diagnostic value of positron emission tomography (PET) in clinical oncology].
    Czech N; Brenner W; Kampen WU; Henze E
    Dtsch Med Wochenschr; 2000 May; 125(18):565-7. PubMed ID: 10835983
    [No Abstract]   [Full Text] [Related]  

  • 19. PET tracers for osteosarcoma.
    Reiman RE
    J Nucl Med; 2004 Aug; 45(8):1424; author reply 1424-5. PubMed ID: 15299071
    [No Abstract]   [Full Text] [Related]  

  • 20. Monitoring of response to radiotherapy with fluorine-18 deoxyglucose PET of head and neck squamous cell carcinomas.
    Sakamoto H; Nakai Y; Ohashi Y; Matsuda M; Sakashita T; Nasako Y; Kitayama H; Kawabe J; Okamura T; Ochi H
    Acta Otolaryngol Suppl; 1998; 538():254-60. PubMed ID: 9879431
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.